Connection

Craig Crosson to Retinal Diseases

Back to Details
This is a "connection" page, showing publications Craig Crosson has written about Retinal Diseases.
Craig Crosson
Connection Strength
1.031
Retinal Diseases
  1. Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-a in the retina. Invest Ophthalmol Vis Sci. 2011 Apr; 52(5):2577-83.
    View in: PubMed
    Score: 0.364
  2. Inhibition of histone deacetylase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci. 2010 Jul; 51(7):3639-45.
    View in: PubMed
    Score: 0.335
  3. Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci. 2005 Mar; 46(3):1092-8.
    View in: PubMed
    Score: 0.238
  4. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J Ocul Pharmacol. 1990; 6(4):293-9.
    View in: PubMed
    Score: 0.083
  5. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 2001 Feb 02; 489(2-3):270-6.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.